What Does the Research Say?
LL-37 has a growing body of research demonstrating broad-spectrum antimicrobial activity against bacteria (including antibiotic-resistant strains like MRSA), viruses, and fungi. It disrupts bacterial biofilms — structured bacterial communities that are notoriously resistant to antibiotics and a major factor in chronic, recurring infections. It promotes wound healing through stimulation of cell migration and angiogenesis. It modulates immune responses (can both activate and calm immune cells depending on context). And it works synergistically with conventional antibiotics, potentially restoring effectiveness against resistant strains.
For dogs, LL-37 is particularly relevant for chronic or recurring infections, wounds that won't heal, ear infections with biofilm involvement, and post-surgical infection prevention. The biofilm-disrupting property is especially valuable since biofilms are a major reason many dog ear infections and skin infections keep coming back despite antibiotic treatment.
Weight-Based Dosing Reference
⚠️ Important: Consult your veterinarian for dosing specific to your dog. This is reference information only.
| Size | Weight | Breeds |
|---|---|---|
| Small | Under 25 lbs | Chihuahua, Dachshund, Pomeranian |
| Medium | 25–60 lbs | Beagle, Border Collie, Cocker Spaniel |
| Large | 60–100 lbs | Labrador, Golden Retriever, German Shepherd |
| Giant | Over 100 lbs | Great Dane, Mastiff, Saint Bernard |
🩺 Administration: LL-37 can be administered topically (for wound care and skin infections), by injection (subcutaneous for systemic immune support), or via nebulization (for respiratory infections). Topical is most common for localized infections. Injectable for systemic immune support requires veterinary prescription and supervision. Oral bioavailability is not well-established.
Side Effects & Safety
LL-37 is generally well-tolerated as a naturally occurring immune peptide. Side effects reported in research are primarily related to local application: mild irritation at application/injection sites and temporary redness or swelling. At high systemic doses, LL-37 can potentially trigger excessive inflammatory responses, which is why dosing should be guided by a veterinarian. Dogs with autoimmune conditions should use LL-37 cautiously as it activates immune pathways.
⚠️ Tumor Caution: Peptides promoting tissue repair could theoretically accelerate existing tumors. Vet screening recommended before starting, especially for seniors and cancer-prone breeds.
Where to Get LL-37 for Dogs
🏪 Integrative Peptides (Pettides)
Pet-specific oral supplements. US-made, ≥99% purity, vet-recommended.
Full Review →Related Conditions
FAQ
What is LL-37 used for in dogs?
LL-37 is an antimicrobial peptide used for chronic infections, biofilm-associated infections (recurring ear infections, skin infections), wound healing, and immune defense. It can kill bacteria, viruses, and fungi while also modulating the immune response.
Can LL-37 help with recurring ear infections in dogs?
Potentially. LL-37 is one of the few agents that can disrupt bacterial biofilms, which are a major reason ear infections keep recurring despite antibiotic treatment. Topical application in combination with conventional treatment is the most studied approach.
Is LL-37 an antibiotic?
No — LL-37 is an antimicrobial peptide, not an antibiotic. It kills microorganisms through a different mechanism (membrane disruption) and bacteria are much less likely to develop resistance to it compared to traditional antibiotics. It can also work synergistically with antibiotics.
Veterinary Disclaimer: Educational only. Consult a licensed vet before starting any supplement. Affiliate Disclosure